(VAPX) Vanguard FTSE Developed - Ratings and Ratios
Australia, Hong Kong, Singapore, South Korea, Taiwan
Description: VAPX Vanguard FTSE Developed
The Vanguard FTSE Developed Asia Pacific ex Japan UCITS ETF USD Distributing CHF is an exchange-traded fund that tracks the FTSE Developed Asia Pacific ex Japan Index, providing investors with exposure to a diversified portfolio of equities in the Asia-Pacific region, excluding Japan. The fund is listed on the Swiss exchange and is denominated in Swiss Francs.
The ETFs investment objective is to replicate the performance of the underlying index, which comprises a broad range of large-cap and mid-cap stocks from developed markets in Asia-Pacific, excluding Japan. The funds holdings are likely to be concentrated in countries such as Australia, Hong Kong, and Singapore, with a mix of industries including financials, industrials, and consumer staples.
Key economic drivers for this ETF include GDP growth rates, interest rates, and trade balances in the Asia-Pacific region. The funds performance is also influenced by currency fluctuations, particularly against the US dollar and Swiss Franc. Investors should monitor macroeconomic indicators such as inflation rates, unemployment rates, and consumer confidence indices to gauge the overall health of the regions economy.
To evaluate the ETFs performance, investors can track key metrics such as tracking error, which measures the funds deviation from the underlying index. Other relevant KPIs include the funds expense ratio, dividend yield, and liquidity metrics such as average daily trading volume and bid-ask spreads.
The ETFs Assets Under Management (AUM) of 1.086 billion CHF indicate a moderate level of investor interest, which can impact liquidity and trading costs. Investors should also be aware of the funds distribution yield and the potential impact of withholding taxes on dividend income.
VAPX ETF Overview
Market Cap in USD | 1,348m |
Category | Asia-Pacific ex-Japan Equity |
TER | 0.15% |
IPO / Inception | 2013-05-21 |
VAPX ETF Ratings
Growth Rating | 7.85% |
Fundamental | - |
Dividend Rating | 46.5% |
Return 12m vs S&P 500 | -8.39% |
Analyst Rating | - |
VAPX Dividends
Dividend Yield 12m | 2.63% |
Yield on Cost 5y | 3.12% |
Annual Growth 5y | 6.74% |
Payout Consistency | 91.8% |
Payout Ratio | % |
VAPX Growth Ratios
Growth Correlation 3m | 94.6% |
Growth Correlation 12m | 21.4% |
Growth Correlation 5y | -33.8% |
CAGR 5y | 3.66% |
CAGR/Max DD 5y | 0.12 |
Sharpe Ratio 12m | -0.08 |
Alpha | -7.83 |
Beta | 0.769 |
Volatility | 13.60% |
Current Volume | 11.9k |
Average Volume 20d | 8.6k |
Stop Loss | 22.5 (-3.1%) |
Signal | -1.39 |
What is the price of VAPX shares?
Over the past week, the price has changed by -2.17%, over one month by +0.69%, over three months by +8.19% and over the past year by +5.93%.
Is Vanguard FTSE Developed a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VAPX is around 28.01 CHF . This means that VAPX is currently undervalued and has a potential upside of +20.63% (Margin of Safety).
Is VAPX a buy, sell or hold?
What are the forecasts/targets for the VAPX price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 31.3 | 34.9% |
VAPX Fundamental Data Overview
Market Cap CHF = 1.09b (1.09b CHF * 1.0 CHF.CHF)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 CHF
Beta = 0.0
Revenue TTM = 0.0 CHF
EBIT TTM = 0.0 CHF
EBITDA TTM = 0.0 CHF
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.09b CHF (1.09b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 1.09b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.09b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(1.09b)/V(0.0) * Re(8.85%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 8.85% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)